CREPT, a tumor-related gene significantly associates with the poor overall survival (OS) of CRC, promotes the CRC metastasis by recruiting p300 and enhancing the acetylation of H3K27 and H4 in the c-myc promoter region to directly control its transcriptional efficacy[17, 18]. The gene discussed is EP300; the disease is neoplasm.